KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
Clinical trial NCT03342937 · COMPLETED
Trial details
- NCT number
- NCT03342937
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2023-02-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.